Charles Sherman
Internal Medicine · Bay Minette, ALNPI 1851328579
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $379 and has fallen 89.2% since, to $41 in 2025.
Across 77 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$244
- Johnson & Johnson$125
- AbbVie$99
- Lilly USA, LLC$72
- Merck$63
- Bayer$60
- plus $469 from 16 others
What the payments were for
- Food & beverage$1,132100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $244 |
| Johnson & Johnson | 7 | $125 |
| AbbVie | 5 | $99 |
| Lilly USA, LLC | 5 | $72 |
| Merck | 4 | $63 |
| Bayer | 3 | $60 |
| Pfizer | 4 | $57 |
| Amgen | 4 | $49 |
| Amarin Pharma, Inc. | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $40 |
| GSK | 3 | $39 |
| Biomerieux Inc | 1 | $37 |
| Dexcom, Inc. | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| AstraZeneca | 2 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
How this compares
$1,132 in reported general payments places this provider in the 65th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Bay Minette
- Ryan WeldonBirmingham$458K
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Robert LewisBirmingham$187K
- Rosalind BowlesGadsden$168K
- Sonja PettusJasper$117K
- Bobby WrightsMobile$89K
- Thomas HuddleBirmingham$76K
- Rahel AzizMobile$67K
- Justin HoveyDothan$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.